Form 4 for WEX WEX Inc.
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001309108-23-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-16 | 2023-02-14 | WEX | Cooper David G | CTO | M - OptEx | $102.52 | +12.6K | 19.8K | +177% | +$1.30M |
| D | 2023-02-16 | 2023-02-14 | WEX | Cooper David G | CTO | S - Sale+OE | $197.00 | -16.6K | 6,358 | -72% | -$3.28M |
| DM | 2023-02-16 | 2023-02-14 | WEX | Cooper David G | CTO | M - OptEx | $0.00 | -12.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 8,713 | $99.69 | 19,071 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | S | D | 16,639 | $197.00 | 6,358 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-14 | M | A | 3,222 | $109.66 | 22,997 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | M | A | 704 | $104.95 | 19,775 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2023-02-14 | M | D | 3,222 | $0.00 | 1,617 | D | $109.66 · 2021-03-16 to 2030-03-16 | 3,222 Common Stock | (F2) This stock option will vest with respect to the remaining one-third of these shares on 3/16/2023. |
| 6 | Derivative | Stock Option (right to buy) | 2023-02-14 | M | D | 704 | $0.00 | 0 | D | $104.95 · 2018-03-20 to 2027-03-20 | 704 Common Stock | |
| 7 | Derivative | Stock Option (right to buy) | 2023-02-14 | M | D | 8,713 | $0.00 | 0 | D | $99.69 · — to 2027-05-10 | 8,713 Common Stock | (F1) Half of the performance based non-statutory stock options ("Performance-Based NSOs"), reported on the Reporting Person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs. |